This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Innovator Spotlight: Anna Maria Persdotter Boije
Introduction:
Anna Maria Persdotter Boije is a notable inventor based in Molndal, Sweden. Her contributions to the field of pharmaceuticals have garnered attention, particularly due to her innovative approaches in medicinal chemistry. With a strong focus on developing compounds aimed at treating clinical conditions associated with insulin resistance, Boije showcases the importance of scientific research and innovation in healthcare.
Latest Patents:
Boije holds a patent for her discovery titled "3-Phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of PPAR-alpha." This patent encompasses a compound of formula I, wherein R represents chloro, fluoro, or hydroxy, alongside optical isomers, racemates, and pharmaceutically acceptable salts, prodrugs, solvates, and crystalline forms. This innovative compound plays a crucial role in addressing conditions related to insulin resistance, highlighting its therapeutic potential in improving patient outcomes.
Career Highlights:
Anna Maria works with AstraZeneca AB, a leading global biopharmaceutical company. Her tenure at AstraZeneca has allowed her to engage in groundbreaking research and development, pushing the boundaries of pharmaceutical innovation. With one patent under her name, she demonstrates significant potential for future contributions to the field.
Collaborations:
Throughout her career, Anna Maria has collaborated with esteemed colleagues, including Eva-Lotte Alstermark Lindstedt and Patrick Holm. These collaborations underscore the importance of teamwork in scientific research and the collective goal of advancing healthcare through innovative solutions.
Conclusion:
Anna Maria Persdotter Boije's dedication to innovation in medicinal chemistry and her impactful patent highlight her role as a pivotal figure in the pharmaceutical industry. Her work at AstraZeneca exemplifies how individual inventors can drive significant advancements in healthcare, ultimately benefiting countless patients worldwide. The future looks promising for Boije and her contributions to medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile